200,000+ products from a single source!

sales@angenechem.com

Home > Cyclic Hypervalent Iodine Reagents: Enabling Tools for Bond Disconnection via Reactivity Umpolung

Cyclic Hypervalent Iodine Reagents: Enabling Tools for Bond Disconnection via Reactivity Umpolung

 

Durga Prasad Hari,† Paola Caramenti,† and Jerome Waser


1.INTRODUCTION AND CONTEXT
Organic compounds have a deep impact on our everyday life as drugs, agrochemicals, or materials. Over the last century, organic synthesis has matured as a craft and a science. Guidelines have been conceptualized to harness the fundamental properties of atoms, such as their electronegativity, to select adequate disconnections for bond formation.1 For example, functional groups containing electronegative atoms, such as nitrogen, halogens, oxygens, or sp2 and sp3 hybridized carbons, are best introduced as nucleophiles onto the carbon skeleton of organic compounds (Figure 1a). This approach is highly successful, but does not allow chemists to make all disconnections, as nucleophilic positions cannot be functionalized. To extend the versatility of organic synthesis, Seebach has introduced the concept of Umpolung (reversal of reactivity):2 If the innate reactivity of synthons can be inverted, new disconnections become possible, leading to greater diversity and synthetic efficiency.

 

In this context, hypervalent iodine reagents have taken a privileged position based on the work of pioneers such as Beringer, Koser, Valvoglis, Moriarty, Zhdankin, Kita, Ochiai, and many others (Figure 1b).3 Both iodanes and iodonium salts allow the Umpolung of many nucleophiles into electrophilic synthons. Even if the concept of hypervalency is still a subject of controversy,4 it has been successfully used to rationalize the exceptional properties of hypervalent iodine reagents. However, their high reactivity can also lead to instability in the presence of strong bases, transition metals or when heating. In this context, benziodoxol(on)es (BX, Figure 1c), a class of cyclic hypervalent iodine reagents, have shown increased stability due to the inclusion of the iodine atom into a heterocycle.5,6 In particular, the groups of Ochiai and Zhdankin successively reported stable ethynyl (EBX),7,8 azido (ABX),9 and cyano (CBX)10 benziodoxol(on)es. A further advantage of BX reagents is the modulation of their reactivity through the trans-effect in the hypervalent bond.11 Derivatives bearing carboxy, isopropyl, and hexafluoroisopropyl substituents have been most broadly used. For many years, structural studies on benziodoxolones have dominated the field, with few attempts in developing new synthetic applications. The situation changed in 2006, when Togni and co-workers reported the use of benziodoxol(on)es for trifluoromethylation.12 The so-called Togni reagents are now broadly used for the introduction of pharmaceutically relevant trifluoromethyl groups on organic compounds.13 Since 2008, our group has explored the potential of other BX reagents for group transfer reactions. We demonstrated that this class of reagents constitutes a unique toolbox for synthetic chemistry, which are superior to simple iodonium salts in many direct, transition metal- and photoredox- catalyzed transformations. After having focused on electrophilic alkynylation,14 we moved to azidation and cyanation. In 2017, we introduced a new class of benziodoxolone reagents for the Umpolung of electron-rich heterocycles, in particular indoles and pyrroles. Many other groups have since then used BX compounds in group-transfer reactions.15,16 Herein, we will present an overview of our 10 year journey in the fascinating reactivity of these reagents 


2.ELECTROPHILIC ALKYNYLATION


2.1.Alkynylation of Acidic C−H Bonds
We first encountered EBX reagents in 2010, when using alkynyliodonium salts for the alkynylation of enolates using reported methods.17,18 We were facing serious issues of reproducibility and were not able to induce enantioselectivity under phase-transfer conditions. Building on the higher stability of EBX reagents,7,8 we successfully used TMS-EBX (1a) and TBAF with stabilized enolates to give terminal alkynes 2a−f in excellent yields (Scheme 1).19 Asymmetric induction was now possible using Maruoka’s phase transfer catalyst (4) (Scheme 2).


Two mechanisms can be envisaged (Scheme 3): Addition− elimination on the iodine atom (a) or conjugate addition to the alkyne, followed by reductive elimination and 1,2 shift (b). The use of 13C-labeled reagent 1b led to product 9,19 which is in agreement with the 1,2 shift pathway.
In 2014, as the phase-transfer approach was limited in both scope and enantioselectivity, we reported an alternative strategy to access quaternary stereocenters: Racemic alkynylation, followed by an enantioselective Tsuji−Trost allylation.


2.2.Alkynylation of Heteroatoms
In 2013, we wondered if EBX reagents could also contribute to a more efficient synthesis of thioalkynes. These compounds are usually synthesized by addition of acetylides to oxidized thiol precursors.22 Whereas only disulfides were obtained when the alkynylation was attempted with alkynyliodonium salts, a quantitative yield was realized using TIPS-EBX (1c) (Scheme 5).23,24 The reaction proceeded in 5 min at room temperature in an open flask with a wide range of EBX reagents and thiol or selenol substrates (products 10a−m).
A mechanism for the thiol-alkynylation reaction was proposed based on computational studies (Scheme 6).24 First, thiolate I could attack on the iodine atom of EBX to give II, which then undergoes reductive elimination to give the product. However, intermediate II was not observed in the computational studies.


As an alternative, conjugate addition of thiolate I to give vinyl benziodoxolone III, which undergoes α-addition followed by 1,2 shift, leads to the product. This pathway was observed with a transition state energy of 23 kcal/mol. Nevertheless, a concerted pathway via asynchronous transition state IV with significant Hirshfeld charge separation was identified with a lower energy of 10.8 kcal/mol. In 2015, we further identified a four-atom transition state V leading to β-addition, which is favorable for alkyl groups on EBX, whereas α-addition is favored for electron withdrawing groups.25


The very fast and selective reaction of EBX reagents with thiols under mild conditions motivated us to investigate applications in chemical biology. In 2015, Adibekian and our group reported a method for proteomic profiling of enzymes with hyperactive cysteines in living cells by using the azide- substituted EBX JW-RF-010 (1e) (Scheme 7).26 The utility of the method was further demonstrated by identifying one target of curcumin in HeLa cells.


As a last effort in the area of heteroatom functionalization, we further demonstrated the use of EBX reagents for the alkynylation of other sulfur and phosphorus nucleophiles. Sulfones 11a−e were obtained from Grignard reagents or aryl iodides using DABSO (diazabicycloctane bis(sulfur dioxide)) as sulfur source (Scheme 8)27 and alkynyl phosphorus derivatives 12a−e were synthesized from H-phosphi(na)tes and secondary phosphine oxides (Scheme 9).28


2.3.C−H Alkynylation of Hetero(arenes)
Our research on EBX reagents with simple nucleophiles had been highly successful, and we wondered if they could be also applied in the more complex settings of transition metal catalysis. Since 2007, using alkynyliodonium salts, C−H functionalization had been a major project in our group, but without success, as the sensitive reagents constantly decom- posed in the presence of the metal catalyst. In 2009, we had our first success with the direct alkynylation of indoles using TIPS- EBX (1c) and AuCl as catalyst (Scheme 10a).29 C3 alkynylate indoles 13a−c were obtained in good yields. The formation of C2-alkynylated indoles was observed when the C3 position was blocked (Scheme 10b, products 13d,e).30,31 The direct C−H alkynylation reaction was further extended to pyrroles (Scheme 10c, products 14a−c),32 thiophenes (Scheme 10d, products 15a−c),33 furans (Scheme 10e, products 16a−c),34 benzofurans (Scheme 10f, products 17a−c),35 and anilines and trimethoxy arenes (Scheme 11, products 18a−d).36
Initially, we hypothesized two mechanisms involving either an oxidative mechanism or a π-activation for the C−H alkynylation (Scheme 12).32 Oxidative addition of EBX on Au(I) would give Au(III) intermediate I. Electrophilic auration leads then to II and reductive elimination gives 13f. The π-activation involves coordination of Au(I) to the triple bond to give III, followed by nucleophilic attack leading to IV. Finally, α-elimination followed by 1,2-shift gives 13f. No silicon-shift was observed when C13 labeled reagent 1b was used. This result supports the oxidative mechanism. However, Ariafard found by computations that both the oxidative and π-activation mechanisms were too high in energy and proposed a iodine to gold shift on the alkyne to give intermediate V.37 Indole addition to V, followed by β- elimination and rearomatization would lead to 13f. Common to the three mechanisms is an electrophilic aromatic substitution step, which explains the high regioselectivity observed. In 2013, we also reported a palladium-catalyzed selective C2 alkynyla- tion.38 Other research groups later demonstrated that EBX reagents can be used for C−H alkynylation using a broad range of transition metal catalysts.


2.4.Alkynylation Involving Domino Reactions
In our work on heterocycles, we had demonstrated that EBX reagents could be used for a single sp2−sp bond formation. We then investigated their use in domino reactions leading to the alkynylation of sp3 centers. We reported the first example of such a transformation with the palladium-catalyzed intramolecular oxy- and amino-alkynylation of olefins using phenols, carboxylic acids, and imides as nucleophiles.


Initially, we proposed a mechanism involving a Pd(IV) intermediate II (Scheme 14).39 Oxy/aminopalladation of the olefin gives intermediate I, which undergoes oxidative addition with TIPS-EBX (1c) to give II, followed by reductive elimination. Ariafard proposed a different mechanism involving formation of palladium allenylidene intermediate III (in equilibrium with the iodine bound alkynyl palladium complex IV) based on computational studies.41 1,2-Shift followed by β- elimination of 2-iodobenzoic acid leads to the product.
We then wondered then if domino processes could be also used for the synthesis of alkynylated heterocycles not accessible via C−H functionalization. As a proof of concept, we realized a one-pot synthesis of C3-alkynylated indoles 23a−c upon reaction of anilines with TIPS-EBX (1c) using a gold catalyst.

Over 100,000 products now available from Angene:

CAS No. 1137475-34-3

2-Pyrazinecarbonitrile, 5-[[6-[[2-(4-piperidinyl)ethyl]amino]-4-pyrimidinyl]amino]-

Catalog No.:AG0009K7 MDL No.:

MF:C16H20N8 MW:324.3836

CAS No. 1137475-35-4

2-Pyrazinecarbonitrile, 5-[[6-[(4-pyridinylmethyl)amino]-4-pyrimidinyl]amino]-

Catalog No.:AG0009K6 MDL No.:

MF:C15H12N8 MW:304.3094

CAS No. 1137475-36-5

2-Pyrazinecarbonitrile, 5-[[6-[methyl(4-piperidinylmethyl)amino]-4-pyrimidinyl]amino]-

Catalog No.:AG0009K5 MDL No.:

MF:C16H20N8 MW:324.3836

CAS No. 1137475-37-6

2-Pyrazinecarbonitrile, 5-[[6-[[1-(4-piperidinyl)ethyl]amino]-4-pyrimidinyl]amino]-

Catalog No.:AG0009K4 MDL No.:

MF:C16H20N8 MW:324.3836

CAS No. 1137475-38-7

2-Pyrazinecarbonitrile, 5-[[6-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]-4-pyrimidinyl]amino]-

Catalog No.:AG0009K3 MDL No.:

MF:C15H17N7O MW:311.3418

CAS No. 1137475-40-1

2-Pyrazinecarbonitrile, 5-[[6-[(3-methoxypropyl)amino]-4-pyrimidinyl]amino]-

Catalog No.:AG0009K2 MDL No.:

MF:C13H15N7O MW:285.3045

CAS No. 1137475-42-3

2-Pyrazinecarbonitrile, 5-[[6-[[(tetrahydro-2-furanyl)methyl]amino]-4-pyrimidinyl]amino]-

Catalog No.:AG0009K1 MDL No.:

MF:C14H15N7O MW:297.3152

CAS No. 1137475-44-5

2-Pyrazinecarbonitrile, 5-[[6-[[(tetrahydro-2H-pyran-3-yl)methyl]amino]-4-pyrimidinyl]amino]-

Catalog No.:AG0009K0 MDL No.:

MF:C15H17N7O MW:311.3418

CAS No. 1137475-51-4

2-Pyrazinecarbonitrile, 5-[[6-[(3-hydroxypropyl)amino]-4-pyrimidinyl]amino]-

Catalog No.:AG0009JZ MDL No.:

MF:C12H13N7O MW:271.2779

CAS No. 1137475-52-5

2-Pyrazinecarbonitrile, 5-[[6-[(4-hydroxybutyl)amino]-4-pyrimidinyl]amino]-

Catalog No.:AG0009JY MDL No.:

MF:C13H15N7O MW:285.3045

CAS No. 1137475-53-6

2-Pyrazinecarbonitrile, 5-[[6-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-4-pyrimidinyl]amino]-

Catalog No.:AG0009JX MDL No.:

MF:C12H13N7O2 MW:287.2773

CAS No. 1137475-54-7

2-Pyrazinecarbonitrile, 5-[[6-[4-(hydroxymethyl)-1-piperidinyl]-4-pyrimidinyl]amino]-

Catalog No.:AG0009JW MDL No.:

MF:C15H17N7O MW:311.3418

CAS No. 1137475-57-0

Pyridine, 2-bromo-4-chloro-5-nitro-

Catalog No.:AG0009JV MDL No.:MFCD17014975

MF:C5H2BrClN2O2 MW:237.4386

CAS No. 1137475-61-6

2-Pyrazinecarbonitrile, 5-[[5-amino-4-(methylamino)-2-pyridinyl]amino]-

Catalog No.:AG0009JU MDL No.:

MF:C11H11N7 MW:241.2519

CAS No. 1137475-62-7

2-Pyrazinecarbonitrile, 5-[[5-amino-4-[(2-aminoethyl)amino]-2-pyridinyl]amino]-

Catalog No.:AG0009JT MDL No.:

MF:C12H14N8 MW:270.2932

CAS No. 1137475-63-8

2-Pyrazinecarbonitrile, 5-[[5-amino-4-[[2-(dimethylamino)ethyl]amino]-2-pyridinyl]amino]-

Catalog No.:AG0009JS MDL No.:

MF:C14H18N8 MW:298.3463

CAS No. 1137475-64-9

2-Pyrazinecarbonitrile, 5-[[5-amino-4-(4-piperidinylamino)-2-pyridinyl]amino]-

Catalog No.:AG0009JR MDL No.:

MF:C15H18N8 MW:310.3570

CAS No. 1137475-66-1

2-Pyrazinecarbonitrile, 5-[[5-amino-4-[(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)amino]-2-pyridinyl]amino]-

Catalog No.:AG0009JQ MDL No.:

MF:C18H22N8 MW:350.4209

CAS No. 1137475-67-2

2-Pyrazinecarbonitrile, 5-[[5-amino-4-[(1-methyl-4-piperidinyl)amino]-2-pyridinyl]amino]-

Catalog No.:AG0009JP MDL No.:

MF:C16H20N8 MW:324.3836

CAS No. 1137475-85-4

Acetamide, N-[6-[(5-cyano-2-pyrazinyl)amino]-4-[(4-piperidinylmethyl)amino]-3-pyridinyl]-

Catalog No.:AG0009JO MDL No.:

MF:C18H22N8O MW:366.4203

CAS No. 1137475-91-2

3-Pyridinecarboxylic acid, 6-[(5-cyano-2-pyrazinyl)amino]-4-[(4-piperidinylmethyl)amino]-, methyl ester

Catalog No.:AG0009JN MDL No.:

MF:C18H21N7O2 MW:367.4050

CAS No. 1137475-97-8

3-Pyridinecarboxylic acid, 6-[(5-cyano-2-pyrazinyl)amino]-4-[(1-methyl-4-piperidinyl)amino]-, methyl ester

Catalog No.:AG0009JM MDL No.:

MF:C18H21N7O2 MW:367.4050

CAS No. 1137476-04-0

3-Pyridinecarboxylic acid, 6-[(5-cyano-2-pyrazinyl)amino]-4-[[(3-methyl-3-oxetanyl)methyl]amino]-, methyl ester

Catalog No.:AG0009JL MDL No.:

MF:C17H18N6O3 MW:354.3632

CAS No. 1137476-13-1

2-Pyrazinecarbonitrile, 5-[[5-chloro-4-(4-morpholinyl)-2-pyridinyl]amino]-

Catalog No.:AG0009JK MDL No.:

MF:C14H13ClN6O MW:316.7456

CAS No. 1137476-15-3

2-Pyrazinecarbonitrile, 5-[[4-(4-morpholinyl)-5-phenyl-2-pyridinyl]amino]-

Catalog No.:AG0009JJ MDL No.:

MF:C20H18N6O MW:358.3965

CAS No. 1137476-32-4

2-Pyrazinecarbonitrile, 5-[[5-amino-4-(4-piperidinylmethoxy)-2-pyridinyl]amino]-

Catalog No.:AG0009KP MDL No.:

MF:C16H19N7O MW:325.3684

CAS No. 1137476-36-8

2-Pyrazinecarbonitrile, 5-[[5-amino-4-[(3-piperidinylmethyl)amino]-2-pyridinyl]amino]-

Catalog No.:AG0009KO MDL No.:

MF:C16H20N8 MW:324.3836

CAS No. 1137476-38-0

2-Pyrazinecarbonitrile, 5-[[5-amino-4-[(3-aminopropyl)amino]-2-pyridinyl]amino]-

Catalog No.:AG0009KN MDL No.:

MF:C13H16N8 MW:284.3197

CAS No. 1137476-42-6

2-Pyrazinecarbonitrile, 5-[[5-amino-4-(cyclohexylamino)-2-pyridinyl]amino]-

Catalog No.:AG0009KM MDL No.:

MF:C16H19N7 MW:309.3690

CAS No. 1137476-47-1

2-Pyrazinecarbonitrile, 5-[[5-amino-4-[(cyclohexylmethyl)amino]-2-pyridinyl]amino]-

Catalog No.:AG0009KL MDL No.:

MF:C17H21N7 MW:323.3955

CAS No. 1137476-48-2

2-Pyrazinecarbonitrile, 5-[[5-amino-4-[(3-amino-3-phenylpropyl)amino]-2-pyridinyl]amino]-

Catalog No.:AG0009KK MDL No.:

MF:C19H20N8 MW:360.4157

CAS No. 1137476-49-3

2-Pyrazinecarbonitrile, 5-[[5-amino-4-[(2-piperidinylmethyl)amino]-2-pyridinyl]amino]-

Catalog No.:AG0009KJ MDL No.:

MF:C16H20N8 MW:324.3836

CAS No. 1137476-66-4

2-Pyrazinecarbonitrile, 5-[[4-[(1-methyl-4-piperidinyl)amino]-5-(1H-pyrrol-1-yl)-2-pyridinyl]amino]-

Catalog No.:AG0009KI MDL No.:

MF:C20H22N8 MW:374.4423

CAS No. 1137476-95-9

3-Pyridinecarboxylic acid, 6-[(5-cyano-2-pyrazinyl)amino]-4-[(2-piperidinylmethyl)amino]-, methyl ester

Catalog No.:AG0009KH MDL No.:

MF:C18H21N7O2 MW:367.4050

CAS No. 1137476-98-2

3-Pyridinecarboxylic acid, 6-[(5-cyano-2-pyrazinyl)amino]-4-[(hexahydro-1H-azepin-4-yl)amino]-, methyl ester

Catalog No.:AG0009KG MDL No.:

MF:C18H21N7O2 MW:367.4050

CAS No. 1137477-03-2

3-Pyridinecarboxylic acid, 6-[(5-cyano-2-pyrazinyl)amino]-4-(4-piperidinylamino)-, methyl ester

Catalog No.:AG0009KF MDL No.:

MF:C17H19N7O2 MW:353.3785

CAS No. 1137477-07-6

3-Pyridinecarboxylic acid, 6-[(5-cyano-2-pyrazinyl)amino]-4-[(2-morpholinylmethyl)amino]-, methyl ester

Catalog No.:AG0009KE MDL No.:

MF:C17H19N7O3 MW:369.3779

CAS No. 1137477-34-9

3-Pyridinecarboxamide, 6-[(5-cyano-2-pyrazinyl)amino]-4-[(4-piperidinylmethyl)amino]-

Catalog No.:AG0009KD MDL No.:

MF:C17H20N8O MW:352.3937

CAS No. 1137477-38-3

3-Pyridinecarboxylic acid, 6-[(5-cyano-2-pyrazinyl)amino]-4-[(1-methyl-4-piperidinyl)amino]-

Catalog No.:AG0009KC MDL No.:

MF:C17H19N7O2 MW:353.3785

CAS No. 1137477-49-6

2-Pyrazinecarbonitrile, 5-[[5-chloro-4-[(1-methyl-4-piperidinyl)amino]-2-pyridinyl]amino]-

Catalog No.:AG0009KB MDL No.:

MF:C16H18ClN7 MW:343.8140

CAS No. 1137477-50-9

2-Pyrazinecarbonitrile, 5-[[5-chloro-4-[methyl(1-methyl-4-piperidinyl)amino]-2-pyridinyl]amino]-

Catalog No.:AG0009KA MDL No.:

MF:C17H20ClN7 MW:357.8406

CAS No. 1137478-25-1

2-Pyrazinecarbonitrile, 5-[[5-(3-hydroxypropyl)-4-[(4-piperidinylmethyl)amino]-2-pyridinyl]amino]-

Catalog No.:AG0009K9 MDL No.:

MF:C19H25N7O MW:367.4481

CAS No. 1137478-29-5

2-Pyrazinecarbonitrile, 5-[[5-(3-hydroxy-1-propyn-1-yl)-4-[(4-piperidinylmethyl)amino]-2-pyridinyl]amino]-

Catalog No.:AG0009K8 MDL No.:

MF:C19H21N7O MW:363.4163

CAS No. 113748-04-2

1,3-Dioxolane, 2-butyl-2-methoxy-

Catalog No.:AG0009KW MDL No.:

MF:C8H16O3 MW:160.2108

CAS No. 113748-36-0

Morpholine, 4-(2,4-dinitro-1-naphthalenyl)-

Catalog No.:AG0009KV MDL No.:

MF:C14H13N3O5 MW:303.2701

CAS No. 113749-07-8

Nonanoic acid, 3-acetyl-, methyl ester

Catalog No.:AG0009KU MDL No.:

MF:C12H22O3 MW:214.3013

CAS No. 113749-12-5

2(3H)-Furanone, 3-butyl-5-(phenylmethyl)-

Catalog No.:AG0009KT MDL No.:

MF:C15H18O2 MW:230.3022

CAS No. 113749-54-5

Glycine, N,N-bis(2-pyridinylmethyl)-

Catalog No.:AG0009KS MDL No.:

MF:C14H15N3O2 MW:257.2878

CAS No. 113753-10-9

Guanosine, 2'-deoxyguanylyl-(3'→5')-2'-deoxy-, monosodium salt (9CI)

Catalog No.:AG0009KR MDL No.:

MF:C20H25N10NaO10P MW:619.4370

CAS No. 113755-06-9

1,3,4-Thiadiazole-2(3H)-thione, 5,5'-dithiobis[3-(phenylmethyl)- (9CI)

Catalog No.:AG0009KQ MDL No.:

MF:C18H14N4S6 MW:478.7206

CAS No. 1137576-38-5

Pyrimidine, 4,6-dichloro-5-iodo-

Catalog No.:AG0009L2 MDL No.:MFCD18072689

MF:C4HCl2IN2 MW:274.8746

CAS No. 1137576-47-6

5-Pyrimidinemethanol, 4,6-dichloro-2-(methylthio)-α-phenyl-

Catalog No.:AG0009L1 MDL No.:

MF:C12H10Cl2N2OS MW:301.1916

CAS No. 1137576-61-4

Pyrimidine, 2,4,6-trichloro-5-iodo-

Catalog No.:AG0009L0 MDL No.:MFCD18072685

MF:C4Cl3IN2 MW:309.3197

CAS No. 113760-34-2

2-Morpholinecarboxamide, N,N-diethyl-6-(1H-indol-4-yl)-4-methyl-, methanesulfonate (9CI)

Catalog No.:AG0009LC MDL No.:

MF:C19H29N3O5S MW:411.5157

CAS No. 113760-65-9

Acetic acid, 2,2'-[carbonothioylbis(thio)]bis-, dibutyl ester (9CI)

Catalog No.:AG0009LB MDL No.:

MF:C13H22O4S3 MW:338.5064

CAS No. 1137606-74-6

2-Pyrazinecarbonitrile, 6-fluoro-3,4-dihydro-3-oxo-, compd. with N-cyclohexylcyclohexanamine (1:1)

Catalog No.:AG0009KZ MDL No.:

MF:C17H25FN4O MW:320.4050

CAS No. 113761-61-8

Benzoic acid, 2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]-3-methyl-

Catalog No.:AG0009LA MDL No.:

MF:C14H14N2O5 MW:290.2714

CAS No. 113761-64-1

Benzoic acid, 2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]-4-methyl-

Catalog No.:AG0009L9 MDL No.:

MF:C14H14N2O5 MW:290.2714

CAS No. 113761-79-8

Benzoic acid, 2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]-6-fluoro-

Catalog No.:AG0009L8 MDL No.:

MF:C13H11FN2O5 MW:294.2352

CAS No. 113761-80-1

Benzoic acid, 2-chloro-6-[(4,6-dimethoxy-2-pyrimidinyl)oxy]-

Catalog No.:AG0009L7 MDL No.:

MF:C13H11ClN2O5 MW:310.6898

CAS No. 1137621-29-4

2-Propenoic acid, 3-[3-[(phenylaMino)sulfonyl]phenyl]-, ethyl ester, (2E)-

Catalog No.:AG0009KY MDL No.:

MF:C17H17NO4S MW:331.3862

CAS No. 1137622-03-7

Benzaldehyde, 5-amino-2-methoxy-

Catalog No.:AG0009KX MDL No.:

MF:C8H9NO2 MW:151.1626

CAS No. 113763-37-4

Benzoic acid, 2-bromo-6-hydroxy-, methyl ester

Catalog No.:AG0009L6 MDL No.:MFCD18398784

MF:C8H7BrO3 MW:231.0434

CAS No. 113763-72-7

Benzoic acid, 2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]-6-methyl-

Catalog No.:AG0009L5 MDL No.:

MF:C14H14N2O5 MW:290.2714

CAS No. 113765-39-2

Phosphoric acid, 3,5-bis(1-methylethyl)phenyl diphenyl ester

Catalog No.:AG0009L4 MDL No.:

MF:C24H27O4P MW:410.4425

CAS No. 113765-56-3

1,3,2-Dioxaborolane, 4-methyl-2-(2-methylphenyl)-

Catalog No.:AG0009L3 MDL No.:

MF:C10H13BO2 MW:176.0200

© 2019 Angene International Limited. All rights Reserved.